On March 16, 2023 Philogen reported that it will attend 19th EADO Congress on April 20-22, 2023 (Press release, Philogen, MAR 16, 2023, View Source [SID1234628940]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Dr. Covelli (CMO), Dr. Elia, Dr. Ravenni, and Dr. Nadal will participate at the event in Rome.

The dermato-oncology team from St. Gallen will give a presentation entitled "Intralesional administration of L19IL2/L19TNF in difficult-to-treat BCC patients shows favorable safety profile and leads to complete remission of tumor lesions"

Moreover, Prof. Dario Neri, CEO and CSO of Philogen, is giving a presentation on the 21st of April 2023 entitled "Innovative targeted therapies in Oncology and beyond".